Cross-Linking-Density-Changeable Microneedle Patch Prepared from a Glucose-Responsive Hydrogel for Insulin Delivery

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Nanotechnology

Background:

• Diabetes mellitus requires effective glucose monitoring and insulin delivery.
• Current insulin delivery methods can be invasive and lack real-time glucose responsiveness.
• Microneedle patches offer a minimally invasive alternative for transdermal drug delivery.

Purpose of the Study:

• To design a simplified, glucose-responsive microneedle patch for automated insulin delivery.
• To develop a hydrogel system with tunable cross-linking density for controlled insulin release.
• To evaluate the glucose-responsive insulin release and in vivo efficacy of the microneedle patch.

Main Methods:

• Fabrication of a microneedle patch using a hydrogel composed of phenylboronic acid-grafted polyallylamine and poly(vinyl alcohol) (PVA).
• Cross-linking of the hydrogel via boronate ester bonds, allowing for glucose-dependent changes in cross-linking density.
• Incorporation of insulin directly into the hydrogel matrix.
• Enhancement of mechanical strength through repeated freezing and thawing of PVA chains.
• Evaluation of glucose-responsive insulin release in vitro and hypoglycemic effects in diabetic rats.

Main Results:

• The microneedle patch hydrogel exhibited fluidity for easy mold filling and direct insulin loading.
• Boronate ester bond cleavage in the presence of glucose led to decreased cross-linking density, increased swelling, and faster insulin release.
• Crystallization of PVA chains improved the mechanical integrity of the microneedle patch.
• The patch demonstrated significant glucose-dependent insulin release capabilities.
• In vivo studies showed effective skin penetration and sustained insulin release in diabetic rats, leading to effective hypoglycemia.

Conclusions:

• A novel, easily prepared glucose-responsive microneedle patch was successfully developed.
• The patch effectively delivers insulin in a glucose-dependent manner, offering a promising approach for diabetes management.
• The tunable cross-linking density and improved mechanical strength make this microneedle patch a viable platform for advanced drug delivery systems.